Accovion GmbH expands global presence in Spain

Monday, June 25, 2012 10:31 AM

Accovion GmbH, a full-service provider of clinical development services based in Eschborn, Germany, has launched an additional subsidiary in Spain.

The subsidiary’s main office in Madrid has opened and is complemented by a regional presence in Barcelona. Together with Poland, Russia, Romania, Czech Republic and U.K., Accovion is now able to present itself with six subsidiaries in total, which further emphasizes the international growth of the company. With its expansion, Accovion aims to offer its clients a broader spectrum of country-specific clinical research expertise providing the quality services that Accovion is known for.

With the expansion, Verónica de Lázaro Vettorello was appointed country director of Spain at Accovian, taking over the business activities in the country.

"Spain represents a key strategic territory for Accovion. When it comes to conducting clinical trials in Europe, Spain is among the top five within Europe,” explained Lázaro Vettorello. "Another important aspect is that the majority of our clients conduct clinical trials in Spain. The country has a very well-established clinical research scenery, excellently educated clinical research professionals (e.g. Spanish association of CROs) and well-known medical hospital quality.”

She added, “Together we will pursue Accovion’s successful development and will further increase our international market share of high value clinical development services.”

Share:          
CWWeekly

March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs